Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Comment by MickeyTJon Mar 31, 2021 9:04pm
134 Views
Post# 32920128

RE:RE:RE:Retail!

RE:RE:RE:Retail!Interesting results!

I'm curious why the second consecutive quarter of big impairment charges of biological assets.  This last quarter, the impairment charge (~$2.7M) is almost 20% of total revenues.  Does anyone know exactly what this is? Is this a writedown of bud that went stale? And why did this start suddenly in Q3 of last year, but prior to that (the previous 2 quarters) there were no losses.

Also, on the projected run rate, I think it's very easy to assume that with each additional store brought on board in Winnipeg there will be a linear growth in realization of revenue but we have to be careful. When D9 opened the St. Vital store ways back I drove all the way from the far end of the city, and I'm sure others did as well. As more stores come on, all the people flocking to one or a few stores previously, will be spread out among the new stores, lessening each stores revenue. Put another way, there will no doubt be increased overall revenue, but the revenue will start to 'flatten'. I could be proven wrong, but do an average store revenue now, and compare it end of the year.

Overall I like the numbers, still no positive EPS, but moving there!
<< Previous
Bullboard Posts
Next >>